Identification of novel scaffolds from an original chemical library as potential antipsychotics

QSAR and Combinatorial Science

Volumn 28, Issue 8, 2009, Pages 856-860

  Gutiérrez de Terán, Hugo ^a   Correia, Carla ^c   Rodríguez, David ^a   Carvalho, Maria Alice ^c   Brea, Jose ^b   Cadavid, María Isabel ^b   Loza, María Isabel ^b   Proença, Maria Fernanda ^c   Areias, Filipe ^b,c  

^a Instituto de Salud Carlos III   (Spain)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^c UNIVERSITY OF MINHO   (Portugal)

Author keywords

5 HT2A; Antipsychotic; Drug design; Purine; Serotonin receptors; Virtual screening

Indexed keywords

BINDING ENERGY; DIGITAL LIBRARIES;

5-HT2A; ANTIPSYCHOTIC; ATYPICAL ANTIPSYCHOTICS; CHEMICAL FAMILY; CHEMICAL LIBRARIES; DRUG DESIGN; INHIBITORY ACTIVITY; PURINE; SEROTONIN RECEPTORS; VIRTUAL SCREENING;

SCAFFOLDS;

6 (PIPERAZIN 1 YL)PURINE; CLOZAPINE; NEUROLEPTIC AGENT; SEROTONIN 2A RECEPTOR; UNCLASSIFIED DRUG;

AUTOMATION; CONFERENCE PAPER; CONTROLLED STUDY; DATA BASE; DRUG IDENTIFICATION; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG SCREENING; DRUG STRUCTURE; HUMAN; MOLECULAR DOCKING; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

EID: 70350362084     PISSN: 1611020X     EISSN: 16110218     Source Type: Journal    
DOI: 10.1002/qsar.200860198     Document Type: Conference Paper

References (24)

1. WHO Fact Sheet Number 265, The World Health Organization, Geneva, Switzerland 2001.
2. J. A. Lieberman, C. A. Johns, J. M. Kane, K. Rai, A. V. Pisciotta, B. L. Saltz, A. Howard, J Clin. Psychiatry 1988, 49, 271-277.
3. H. Y. Meltzer, S. Matsubara, J. C. Lee, Pharmacol. Exp. Ther. 1989, 251, 238-246.
4. B. L. Roth, D. J. Sheffler, W. K. Kroeze, Nat. Rev. Drug Discovery, 2004, 3, 353-359.
5. T. Lengauer, C. Lemmen, M. Rarey, M. Zimmermann, Drug Discov. Today 2004, 9, 27-34.
6. J. H. Nettles, J. L. Jenkins, A. Bender, Z. Deng, J. W. Davies, M. Glick, J. Med. Chem. 2006, 49, 6802-6810
7. E. Gregori-Puigjane, J. Mestres, J. Med. Chem. 2006, 46, 1615-1622.
8. V. Cherezov, D. M. Rosenbaum, M. A. Hanson, S. G. Rasmussen, F. S. Thian, T. S. Kobilka, H. J. Choi, P. Kuhn, W. I. Weis, B. K. Kobilka, R. C. Stevens, Science 2007, 318, 1258-1265.
9. T. Warne, M. J. Serrano-Vega, J. G. Baker, R. Moukhametzianov, P. C. Edwards, R. Henderson, A. G. Leslie, C. G. Tate, G. F. Schertler, Nature 2008, 454, 486-492.
10. J. H. Lange, J. H. Reinders, J. T. Tolboom, J. C. Glennon, H. K. Coolen, C. G. Kruse, J. Med. Chem. 2007, 50, 5103-5108.
11. S. Kortagere, W. J. Welsh, J. Comput. Aided Mol. Des. 2006, 20, 789-802.
12. R. Morphy, Z. Rankovic Z. J. Med. Chem. 2006, 49, 4961-70.
13. InstantJChem, Marvin and Calculator plugins, ChemAxon Ltd, Budapest, Hungary. http://www.chemaxon.com
14. OMEGA and ROCS, Openeye Scientific Software, Santa Fe, NM. http://www.eyesopen.com
15. J. Kirchmair, G. Wolber, C. Laggner, T. Langer, J. Chem. Inf. Model. 2006, 46, 1848-1861.
16. J. E. Mills, P. Dean, J. Comput. Aided Mol. Des. 1996, 10, 607-613.
17. J. Brea, J. Rodrigo, A. Carrieri, F. Sanz, M. I. Cadavid, M. J. Enguix, M. Villazón, G. Mengod, Y. Caro, C. F. Masaguer, E. Raviña, N. B. Centeno, A. Carotti, M. I. Loza, J. Med. Chem. 2002, 45, 54-71.
18. Y. Cheng, W. H. Prusoff, Biochem. Pharmacol. 1973, 22, 3099-3108.
19. P. C. D. Hawkins, A. G. Skillman, A. Nicholls, J. Med. Chem. 2007, 50, 74-82
20. M. J. Alves, M. A. Carvalho, S. Carvalho, A. M. Dias, F. Fernandes, M. F, Proença, Eur. J. Org. Chem. 2007, 4881-4887.
21. J. Brea, M. Castro, M. I. Loza, C. F. Masaguer, E. Raviña, C. Dezi, M. Pastor, F. Sanz, A. Cabrero-Castel, B. Galán-Rodríguez, E. Fernández-Espejo, R. Maldonado, P. Robledo, Neuropharmacology 2006, 51, 251-562
22. T. Ladduwahetty, A. L. Boase, A. Mitchinson, C. Quin, S. Patel, K. Chapman, A. M. MacLeod, Bioorg. Med. Chem. Lett. 2006, 16, 3201-3204.
23. S. W. Muchmore, A. J. Souers, I. Akritopoulou-Zanze, Chem. Biol. Drug Des. 2006, 67, 174-176.
24. J. Selent, L. López, F. Sanz, M. Pastor, ChemMedChem 2008, 3, 1194-1198.